GTHX - G1 Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - GTHX (1560241)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
27 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-03-18
GTHXUmstead John W. VCFOS - Sale$3.02-6,547123,896-5%-$19,752
D
2024-02-12
GTHXMalik RajeshChief Medical OfficerS - Sale+OE$4.62-28,600169,938-14%-$132,143
DM
2024-01-03
GTHXUmstead John W. VCFOS - Sale+OE$3.09-743130,443-1%-$2,298
DM
2024-01-03
GTHXMalik RajeshChief Medical OfficerS - Sale+OE$3.08-3,740169,938-2%-$11,537
D
2024-01-03
GTHXPerry AndrewChief Commercial OfficerS - Sale+OE$3.12-2,41387,102-3%-$7,526
D
2024-01-03
GTHXBailey John E. (Jack) Jr.Pres, CEOS - Sale+OE$3.12-11,686489,594-2%-$36,447
DM
2024-01-03
GTHXAvagliano MarkChief Business OfficerS - Sale+OE$3.09-4,081117,834-3%-$12,601
DM
2024-01-03
GTHXMurdock Terry LCOOS - Sale+OE$3.08-3,740103,638-3%-$11,537
2024-01-02
GTHXBailey John E. (Jack) Jr.Pres, CEOS - Sale$3.27-32,983400,580-8%-$108,006
D
2023-12-11
GTHXMalik RajeshChief Medical OfficerS - Sale+OE$3.41-33,839136,378-20%-$115,522
D
2023-08-08
GTHXVelleca Mark A.DirS - Sale+OE$2.00-60,000116,000-34%-$119,974
2023-07-05
GTHXPerry AndrewChief Commercial OfficerS - Sale$2.45-35555,945-1%-$871
2023-07-05
GTHXMurdock Terry LCOOS - Sale$2.45-1,36170,078-2%-$3,339
2023-07-05
GTHXMalik RajeshChief Medical OfficerS - Sale$2.45-1,361136,378-1%-$3,339
2023-07-05
GTHXBailey John E. (Jack) Jr.Pres, CEOS - Sale$2.45-2,719433,563-1%-$6,672
DM
2023-01-04
GTHXMoses Jennifer K.CFOS - Sale+OE$5.52-2,36857,820-4%-$13,080
DM
2023-01-04
GTHXMurdock Terry LCOOS - Sale+OE$5.52-2,36836,439-6%-$13,080
D
2023-01-04
GTHXPerry AndrewChief Commercial OfficerS - Sale+OE$5.58-82021,300-4%-$4,572
DM
2023-01-04
GTHXMalik RajeshChief Medical OfficerS - Sale+OE$5.52-2,368102,739-2%-$13,080
DM
2023-01-04
GTHXHanson James S.GCS - Sale+OE$5.52-2,36841,087-5%-$13,080
DM
2023-01-03
GTHXBailey John E. (Jack) Jr.Pres, CEOS - Sale+OE$5.81-37,626276,282-12%-$218,714
D
2022-10-18
GTHXVelleca Mark A.DirS - Sale+OE$11.70-15,000116,000-11%-$175,490
D
2022-09-20
GTHXVelleca Mark A.DirS - Sale+OE$13.50-20,000116,000-15%-$270,044
D
2022-09-13
GTHXMalik RajeshChief Medical OfficerS - Sale+OE$15.71-18,00073,207-20%-$282,746
D
2022-08-16
GTHXVelleca Mark A.DirS - Sale+OE$12.64-80,000116,000-41%-$1,010,904
2022-07-05
GTHXMurdock Terry LCOOS - Sale$5.17-64820,907-3%-$3,351
2022-07-05
GTHXMalik RajeshChief Medical OfficerS - Sale$5.17-64873,207-1%-$3,351

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top